Skip to content

Medical-device intelligence

Cardiovascular Diagnostics, Inc.: FDA clearances and recalls

Research Cardiovascular Diagnostics, Inc. in public FDA records: applicant and recalling-firm names, product codes, clearance history, and recall records.

Names and coverage

This profile groups matching applicant and recalling-firm names found in covered FDA records. It does not imply a complete corporate family, current ownership, or every product marketed under a brand.

Names observed in the source

Capitalization and punctuation variants are normalized. Customer-entered watchlist aliases remain private.

Product codes in this company’s records

Record activity in this scope

13 clearance records and 0 recall records in the covered releases, across 1 source company names and 8 product codes. Dated history runs from May 10, 1995 to Aug 23, 2002.

Monthly counts through October 2026
Month510(k) decisionsRecall initiations
October 202500
November 202500
December 202500
January 202600
February 202600
March 202600
April 202600
May 202600
June 202600
July 202600
August 202600
September 202600
October 202600

Product codes represented

All-history totals use the covered releases; monthly counts stop at the last calendar month covered by both sources. Clearances use decision dates; recalls use initiation dates. 0 records lack the required date and are excluded from monthly counts. These are records, not product launches, market share, incidence rates, or comparative safety. Feed filters below do not change this overview.

Clearances and recall records

13 matching records
Device / recordCompany in FDA recordSourceSource date
ENOXAPARIN TEST CARDK013305 · KFFCardiovascular Diagnostics, Inc.510(k)Aug 23, 2002FDA decision date
(TAS) LOW RANGE HEPARIN MANAGEMENT CARD RAPIDPOINTK994194 · JBPCardiovascular Diagnostics, Inc.510(k)Mar 28, 2000FDA decision date
HMP CONTROLS (TAS) RAPIDPOINTK994159 · GGNCardiovascular Diagnostics, Inc.510(k)Feb 15, 2000FDA decision date
RAPIDPOINT ACCENT, MODEL 2000, RAPIDPOINT COAG HEPARIN TITRATION TEST, RAPIDPOINT COAG PROTAMINE RESPONSE TESTK993519 · JOXCardiovascular Diagnostics, Inc.510(k)Jan 14, 2000FDA decision date
TAS ANALYZER, MODEL 1009K990566 · JPACardiovascular Diagnostics, Inc.510(k)May 14, 1999FDA decision date
TAS RESULTS DATA ACQUISITION SYSTEM (TRAQS)K981206 · GKPCardiovascular Diagnostics, Inc.510(k)May 26, 1998FDA decision date
THROMBOLYTIC ASSESSMENT SYSTEM LOW RANGE HEPARIN MANAGEMENT TEST CONTROLSK981178 · GGNCardiovascular Diagnostics, Inc.510(k)Apr 27, 1998FDA decision date
TAS PT-NCTEST CONTROLSK971748 · GGNCardiovascular Diagnostics, Inc.510(k)May 29, 1997FDA decision date
THROMBOLYTIC ASSESSMENT SYSTEM PROTHROMBIN TIME TEST CONTROLSK961814 · GIZCardiovascular Diagnostics, Inc.510(k)Aug 13, 1996FDA decision date
TAS A PTT TEST CONTROLSK961189 · GGNCardiovascular Diagnostics, Inc.510(k)Jun 5, 1996FDA decision date
TAS HMT CONTROLSK960234 · GGNCardiovascular Diagnostics, Inc.510(k)May 30, 1996FDA decision date
PROTHROMBIN TIME TEST CARDK954625 · GJSCardiovascular Diagnostics, Inc.510(k)Mar 11, 1996FDA decision date
HEPARIN MANAGEMENT TEST CARD; HMT CARDK943283 · KFFCardiovascular Diagnostics, Inc.510(k)May 10, 1995FDA decision date

Useful context

Device classifications

FDA dataset:

Last successful check: Nov 22, 2026

Source classifications may change.

510(k) clearances

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset monthly.

Recall records

FDA dataset:

Last successful check: Nov 22, 2026

FDA publishes this dataset weekly.

Keep this research moving.

Follow ten competitors and ten product codes. Get matching changes in your dashboard and a weekly brief, for $49/month.

Start a 14-day free trial ↗